The main goal of this project is to enhance the value of current portfolio of products, specifically NIPTIFY (non-invasive prenatal test, NIPT) for foetal health screening, by enhancing the data received from a single blood sample.
The long-term goal is to provide a personalized medicine solution for prenatal care that is cost-effective and easily scalable. The development of innovative products, as NIPTIFY+, including services and processes supported by ICT, will lead to the more personalized preventive approach in primary care.
NIPTIFY+ is a non-invasive test, that, in addition to the risks of foetal chromosome abnormalities, allows to determine the risk of the serious diseases of a mother during pregnancy
